Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Tampa, FL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Decatur, GA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Stockbridge, GA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Stockbridge, GA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Chicago, IL
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
New York, NY
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Charlotte, NC
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Raleigh, NC
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Columbus, OH
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Edmond, OK
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Edmond, OK
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Tulsa, OK
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Memphis, TN
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Houston, TX
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Houston, TX
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Seattle, WA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Spokane, WA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
La Palma, CA
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
La Palma, CA
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
Clinical Research Facility
mi
from
Las Cruces, NM
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
Clinical Research Facility
mi
from
Las Cruces, NM
Click here to add this to my saved trials
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/10/2015
mi
from
Rio de Janeiro,
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/10/2015
mi
from
Rio de Janeiro,
Click here to add this to my saved trials
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/14/2015
The Institute for Clinical and Translational Science (ICTS)
mi
from
Irvine, CA
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/14/2015
The Institute for Clinical and Translational Science (ICTS)
mi
from
Irvine, CA
Click here to add this to my saved trials
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/14/2015
Unversity of California, Irvine Healthcare, Dermatology, Gottschalk Medical Plaza
mi
from
Irvine, CA
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Proof-of-Concept Study of IVIg Efficacy in Patients With Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/14/2015
Unversity of California, Irvine Healthcare, Dermatology, Gottschalk Medical Plaza
mi
from
Irvine, CA
Click here to add this to my saved trials
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Autoimmune Diseases
Status: Enrolling
Updated:  7/20/2015
Duke University Health System
mi
from
Durham, NC
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Severe Autoimmune Diseases
Status: Enrolling
Updated: 7/20/2015
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  8/31/2015
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 8/31/2015
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  8/31/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Study of LJP 394 (Abetimus Sodium) in Lupus Patients
A Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetic and Pharmacodynamic Effects of Abetimus Sodium in Patients With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 8/31/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Abel Buchheim Pharmaceutical Research
mi
from
Miami, FL
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Abel Buchheim Pharmaceutical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Northwestern University School of Medicine
mi
from
Chicago, IL
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Northwestern University School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Altoona Arthritis and Osteoporosis Center
mi
from
Altoona, PA
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Altoona Arthritis and Osteoporosis Center
mi
from
Altoona, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated:  9/4/2015
Metroplex Clinical Research Center
mi
from
Dallas, TX
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.
Status: Enrolling
Updated: 9/4/2015
Metroplex Clinical Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Levothyroxine in Pregnant SLE Patients
Pilot Double-Blind Placebo Controlled Trial of Levothyroxine in Pregnant Systemic Lupus Erythematosus (SLE) Patients With Autoimmune Thyroid Disease
Status: Enrolling
Updated:  9/9/2015
Johns Hopkins University
mi
from
Baltimore, MD
Levothyroxine in Pregnant SLE Patients
Pilot Double-Blind Placebo Controlled Trial of Levothyroxine in Pregnant Systemic Lupus Erythematosus (SLE) Patients With Autoimmune Thyroid Disease
Status: Enrolling
Updated: 9/9/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autoimmunity in Sisters of Lupus Patients
Mapping Autoimmune Phenotypes in Multiplex Families (MADGC 2)
Status: Enrolling
Updated:  9/9/2015
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Autoimmunity in Sisters of Lupus Patients
Mapping Autoimmune Phenotypes in Multiplex Families (MADGC 2)
Status: Enrolling
Updated: 9/9/2015
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up
Status: Enrolling
Updated:  9/26/2015
National Institute of Environmental Health Sciences (NIEHS)
mi
from
Bethesda, MD
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up
Status: Enrolling
Updated: 9/26/2015
National Institute of Environmental Health Sciences (NIEHS)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
East Carolina University
mi
from
Greenville, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Wake Medical Center
mi
from
Raleigh, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Wake Medical Center
mi
from
Raleigh, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Click here to add this to my saved trials
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated:  9/26/2015
Medical University of South Carolina
mi
from
Columbia, SC
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus Study (CLU) and Disease Progression and Activity in the Carolina Lupus Study
Status: Enrolling
Updated: 9/26/2015
Medical University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated:  9/26/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated: 9/26/2015
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated:  9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Lupus Nephritis: Role of Environmental and Occupational Exposures
Lupus Nephritis: Role of Environmental and Occupational Exposures
Status: Enrolling
Updated: 9/26/2015
NIEHS, Research Triangle Park
mi
from
Research Triangle Park, NC
Click here to add this to my saved trials
Lupus Genetics Studies
Lupus Genetic Studies; Lupus Family Registry & Repository
Status: Enrolling
Updated:  10/13/2015
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Lupus Genetics Studies
Lupus Genetic Studies; Lupus Family Registry & Repository
Status: Enrolling
Updated: 10/13/2015
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Genetic Study of Lupus Patients and Their Families
Gene Mapping in Women With SLE
Status: Enrolling
Updated:  10/13/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Genetic Study of Lupus Patients and Their Families
Gene Mapping in Women With SLE
Status: Enrolling
Updated: 10/13/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
Jonesboro, AR
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
La Jolla, CA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
La Jolla, CA
Click here to add this to my saved trials
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated:  10/29/2015
Questcor Investigational Site
mi
from
La Palma, CA
Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Status: Enrolling
Updated: 10/29/2015
Questcor Investigational Site
mi
from
La Palma, CA
Click here to add this to my saved trials